生命科学资讯
生物技术与制药领域的最新动态
Chutes & Ladders—Bavarian Nordic CEO exits on heels of failed takeover
Servier to widen rare cancer offerings with $2.5B buyout of Day One and glioma drug Ojemda
Servier to buy Day One for $2.5B, gaining rare oncology medicines
Solid Biosciences gets $240M for pipeline; Roche expounds on lupus data
Post-Hoc Live: What will the US government do about China biotech?
现在是持有赛默飞世尔股票的正确时机吗？- TradingView
Is This the Right Time to Hold Thermo Fisher Stock in Your Portfolio? - TradingView
Biopharma’s recent string of CEO splits
Pfizer gets obesity drug approval in China shortly after buying local rights
Lilly plucks Flagship, bluebird vet for regenerative medicine unit; Novo's new China president
赛默飞世尔科技公司$TMO股份被皮特凯恩公司减持 - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Pitcairn Co. - MarketBeat
龙沙集团选定海得拉巴作为其全球能力中心新址 - biospectrumindia.com
Lonza selects Hyderabad as new GCC location - biospectrumindia.com
罗氏宠物肽在二期肥胖试验中展现潜力——医药快讯
Roche’s petrelintide shows promise in Phase II obesity trial - The Pharma Letter
龙沙集团(OTCMKTS:LZAGY)股价跌破50日移动平均线——市场动态解析
Lonza Group (OTCMKTS:LZAGY) Stock Price Crosses Below Fifty Day Moving Average - Here's What Happened - MarketBeat
Thermo Fisher Scientific在爱尔兰开设新配送中心 - 医疗科技洞察
Thermo Fisher Scientific opens new distribution centre in Ireland - Med-Tech Insights
摩根大通增持10x Genomics (TXG) 股份 - MarketBeat
10x Genomics $TXG Shares Bought by JPMorgan Chase & Co. - MarketBeat
CI投资公司减持沃特世公司股份
CI Investments Inc. Trims Stake in Waters Corporation $WAT - MarketBeat
如果赛默飞世尔科技股价再跌30%，你还会持有吗？- Trefis
Would You Still Hold Thermo Fisher Scientific Stock If It Fell Another 30%? - Trefis
龙沙集团将在海得拉巴设立全球能力中心 - BW Healthcare World
Lonza To Establish Global Capability Centre In Hyderabad - BW Healthcare World
龙沙集团海得拉巴全球能力中心：瑞士制药巨头将设立全球能力中心 - 德干先驱报
Lonza GCC Hyderabad: Swiss pharma giant to set up global capability centre - Deccan Herald